BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11310287)

  • 1. [Neuroimaging in multiple sclerosis].
    Rivera VM
    Rev Neurol; 2001 Feb 1-15; 32(3):283-5. PubMed ID: 11310287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroimaging and functional analyses for multiple sclerosis].
    Kira J
    Rinsho Byori; 2000 Sep; 48(9):814-22. PubMed ID: 11051795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R
    J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 5. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple sclerosis and magnetic resonance].
    Jinochová M; Seidl Z; Obenberger J; Krásenský J; Havrdová E; Viták T; Peterová V; Danes J
    Cas Lek Cesk; 2003 Mar; 142(3):144-9. PubMed ID: 12756841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
    Ge Y
    Top Magn Reson Imaging; 2006 Aug; 17(4):295-306. PubMed ID: 17415002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis.
    Bagheri MH; Meshksar A; Nabavizadeh SA; Borhani-Haghighi A; Ashjazadeh N; Nikseresht AR
    Acad Radiol; 2008 Jan; 15(1):15-23. PubMed ID: 18078903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brainstem pseudotumor imaging: atypical manifestation of multiple sclerosis in childhood].
    Gómez-Gosálvez F; Sala AG; Rubio A; Escrivá P; Clemente F; Pérez C; Carbonell J; Menor F
    Rev Neurol; 2001 Feb 1-15; 32(3):296-7. PubMed ID: 11310290
    [No Abstract]   [Full Text] [Related]  

  • 14. Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
    Al-Saeed O; Ismail M; Athyal R; Sheikh M
    Acta Radiol; 2011 Jun; 52(5):570-4. PubMed ID: 21498296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
    Kataoka H; Taoka T; Ueno S
    J Neuroimaging; 2009 Jul; 19(3):246-9. PubMed ID: 19021828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging in multiple sclerosis.
    Francis GS; Evans AC; Arnold DL
    Neurol Clin; 1995 Feb; 13(1):147-71. PubMed ID: 7739501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M; Grossman RI; Filippi M
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging in multiple sclerosis.
    Napoli SQ; Bakshi R
    Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing MR image intensity standardization against tissue characterizability of magnetization transfer ratio imaging.
    Madabhushi A; Udupa JK; Moonis G
    J Magn Reson Imaging; 2006 Sep; 24(3):667-75. PubMed ID: 16878312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of evoked potentials with MR imaging and MR spectroscopy in multiple sclerosis.
    Kraft GH; Richards TL; Heide AC
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):561-7, vi. PubMed ID: 9894109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.